Company news
GC Biopharma Corp. news in 2026
GC Biopharma Corp.'s news releases, calls and decks from 2026, newest first.
GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan
August 24, 2026
GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting
May 4, 2026
GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
April 16, 2026
GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology
April 6, 2026
GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala
March 26, 2026
GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, 'MAV/06'
March 11, 2026